IP Library › Granted Patent US 10,660,688
Granted Patent B2
US 10,660,688 · App. 14/709,060 · Granted May 26, 2020

Cryotherapy device with cryoprotection and methods for performing cryotherapy with cryoprotection

Inventors: Gary Kalser (Winter Park, FL); Gregory L. Mayback (Cooper City, FL)
A61B18/02A61B18/0218A61B2018/00547A61B2018/00791A61B2018/00898A61B2018/0212A61B2018/0293A61B2090/0463
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,660,688
App. No.
14/709,060
Granted
May 26, 2020
Kind
B2
Abstract

A cryoprotective device includes a hollow cryoprotective probe having a distal tip, a removable obturator, and at least one integral temperature sensor monitoring temperature at least adjacent the distal tip. An injector is able to inject a cryoprotective substance (CPS) through the cryoprotective probe and out the distal tip when the obturator is removed. The CPS is of a material that prevents freezing of a substance at which it is injected when adjacent cryotherapy occurs. A processor monitors temperature of the at least one the temperature sensor and can indicate if a preset limit is exceeded.

Claims (12)

1. A cryoprotective device, comprising:

a hollow cryoprotective needle probe shaped to pierce human tissue and having:

a distal tip;

a removable obturator; and

at least one integral temperature sensor monitoring temperature of the tissue that is adjacent the distal tip when the distal tip has pierced the tissue and at least temporarily resides within the tissue;

an injector injecting a cryoprotective substance (CPS) through the cryoprotective probe and out the distal tip into the tissue when the distal tip is within the tissue and the obturator is removed, the CPS preventing freezing of the tissue in which it is injected when adjacent cryotherapy occurs; and

a processor monitoring temperature detected by the at least one temperature sensor.

2. The device according to claim 1 , wherein the CPS comprises a rapid transition polymer.

3. The device according to claim 1 , wherein the CPS comprises an anesthetic.

4. The device according to claim 1 , wherein the CPS comprises dehydrated cells.

5. The device according to claim 4 , wherein the dehydrated cells comprise dehydrated amniotic tissue allograft membranes.

6. The device according to claim 1 , wherein the processor notifies a user if the temperature monitored by the temperature sensor exceeds a preset temperature limit.

Continuity (2)
Provisional Application 61991953 · May 12, 2014
Related Publication 20150320473A1 · Nov 12, 2015
Cited By (2)
US 12,426,594 US 12,453,805